Image Description (Logo1)
Sildenafil Citrate Tablet, Film Coated
Product Images NDC 68788-4111
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68788-4111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical-structure (Chemical Structure)
Chemical structure diagram of the active ingredient sildenafil citrate, showing its molecular arrangement and the citrate moiety.*
Figure-1 (Figure 1)
A line chart comparing systolic blood pressure changes (mmHg) over 24 hours after dose between Sildenafil 100 mg and placebo. The x-axis shows time post-dose in hours, and the y-axis shows systolic blood pressure changes. Two lines represent data trends for Sildenafil and placebo groups.*
Figure-2 (Figure 2)
A line graph showing change in systolic blood pressure (SBP) in mmHG over 8 hours postdose. Two data series compare Doxazosin plus Placebo (gray line) and Doxazosin plus Sildenafil 25 mg (black line), illustrating SBP changes over time.*
Figure-3 (Figure 3)
A line graph showing the change in systolic blood pressure (SBP) in mmHg over time postdose (hours) comparing Doxazosin combined with Placebo versus Doxazosin combined with Sildenafil 50 mg. The x-axis represents time in hours up to 8 hours postdose, and the y-axis shows change in SBP ranging roughly from -50 to 40 mmHg, illustrating differences in blood pressure response between the two treatments.*
Figure-4 (Figure 4)
Line graph showing blood pressure changes over time after dosing, comparing Doxazosin plus Sildenafil 100 mg to Doxazosin plus placebo. The y-axis represents blood pressure change in mmHg, and the x-axis represents time after dosing in hours, ranging from 0 to 8 hours. Two lines illustrate the difference between the combined drug and placebo effects over the measured time period.*
Figure-5 (Figure 5)
A pharmacokinetic plasma concentration-time profile graph showing sildenafil levels in nanograms per milliliter (ng/ml) over 24 hours post dose (hrs). The solid line with circle markers represents the plasma concentrations after administration of a commercial sildenafil tablet, displaying a peak around 1 hour and a gradual decline thereafter.*
Figure-6-1 (Figure 6 1)
A bar chart showing the percentage of patients at endpoint by baseline score categories ranging from 0 to 5. The chart includes multiple bars for each baseline score representing different score subcategories (0 to 5) in a stacked or grouped manner. The y-axis indicates percentage of patients, and the x-axis shows baseline scores.*
Figure-6-2 (Figure 6 2)
A bar chart illustrating the percentage of patients at endpoint categorized by baseline score ranging from 0 to 5. Different bars represent subgroups labeled from 0 to 5, showing varied distributions across baseline scores. The vertical axis shows the percentage of patients, and the horizontal axis indicates baseline scores.*
Figure-7 (Figure 7)
A bar chart depicting the percentage of patients reporting improvement across different treatments. The treatments listed are placebo, sildenafil citrate 25 mg, 50 mg, and 100 mg. Patient improvement percentages increase from 24% with placebo to 82% with the highest dose of sildenafil citrate, showing a dose-related improvement trend.*
Sildenafil Tablets 100mg (Sildenafiltablet 100mg 30tablets Indrad)
Label for Sildenafil Tablets 100 mg by Preferred Pharmaceuticals Inc. The label includes storage instructions, a caution warning about drug transfer, and barcode information. The manufacturer is listed as Torrent Pharmaceuticals Limited. Dosage instructions are shown in both English and Spanish, with spaces for patient-specific directions and dosing schedules. The label also references its generic equivalence to Viagra.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
